Imperial Innovations
We are a technology commercialisation company, combining the activities of technology transfer, intellectual property licensing and protection, company incubation and investment. We are focused on the commercialisation of the most promising opportunities from a broad range of technology sectors, with particular expertise in therapeutics, medtech, engineering & materials and ICT.
About us Our people Investor relations£198.3m
invested in UK innovation
During the six months ended 31 January 2015 we invested £22.4 million in our portfolio.
£346.0m
Raised by Innovations
to support investment in and development of our portfolio of technology businesses.
£1 billion
invested in UK innovation
Alongside co-investors, £1 billion has been committed to our portfolio companies since 2006
£1.4 billion
Research Funding
received each year by the universities we focus on (Imperial, Oxford, Cambridge, UCL)
£22.4m
Invested
During the six months ended 31 January 2015 we invested £22.4 million in our portfolio.
35
Accelerated Growth Companies
The focus of our time and capital
Technology Transfer
Our Technology Transfer team works with Imperial College London academics and students.
We manage the translation of an idea into practice, working with academic inventors throughout the process of commercialisation, leading ultimately to licensing to industry partners, or the creation of new ventures.
Find out more
Ventures
Our ventures team creates, nurtures and invests in new technology ventures based on IP
We work to develop new company opportunities based on leading UK academic research, working with Imperial College London (& our own Technology Transfer team), The Universities of Oxford & Cambridge and UCL.
Find out moreImperial Innovations news
Innovations obtains further £50m loan facility from EIB to strengthen UK biotech & life science investment
£50 million loan facility will strengthen investment rate and scale in medtech ...
Read article
Encouraging trial results for cystic fibrosis gene therapy treatment
Imperial Innovations is pleased to note the announcement this morning that a ...
Read articlePortfolio overview
We have identified four particular areas of expertise, shown in the diagram below. As at 31 January 2015, the value of the top 20 investments in our portfolio stood at £241.3 million.
Portfolio subsectors
- Therapeutics
- Medtech
- Engineering/Materials
- ICT/Digital
| Sector | Investment amount | Investment stage |
| Therapeutics | £25.5m | Listed |
Overview
A clinical-stage specialty biopharmaceutical company developing a range of novel immunotherapies
| Sector | Investment amount | Investment stage |
| Medtech | Seed |
Overview
Complete replacement for knee meniscus
| Sector | Investment amount | Investment stage |
| ICT/Digital | £3.0m | Series A |
Overview
Internet of Things solutions provider specialising in fully integrated business solutions around connected product intelligence.
Investment details
Share price: 482.50p
Key information
Sector: Financial Services
Activities: Technology commercialisation, incubation and investment
EPIC: IVO
Status: AIM
Year end: 31 July